GAR1

GAR1 ribonucleoprotein, the group of H/ACA ribonucleoprotein complex

Basic information

Region (hg38): 4:109815510-109824740

Previous symbols: [ "NOLA1" ]

Links

ENSG00000109534NCBI:54433OMIM:606468HGNC:14264Uniprot:Q9NY12AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GAR1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GAR1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
12
clinvar
1
clinvar
13
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 12 1 0

Variants in GAR1

This is a list of pathogenic ClinVar variants found in the GAR1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-109816184-G-A not specified Uncertain significance (Mar 25, 2024)3280703
4-109816251-C-G not specified Uncertain significance (Apr 08, 2024)3280702
4-109816254-AGGTGGAGGCGGC-A GAR1-related disorder Likely benign (Dec 07, 2022)3051644
4-109816261-G-A not specified Likely benign (Jan 31, 2022)2274733
4-109816354-C-G not specified Uncertain significance (Jun 28, 2022)2386101
4-109816364-C-T not specified Uncertain significance (May 03, 2023)2508143
4-109817987-C-A not specified Uncertain significance (Apr 12, 2025)4028248
4-109818017-A-G not specified Uncertain significance (Sep 12, 2023)2622458
4-109818022-C-A not specified Uncertain significance (Apr 07, 2025)4028247
4-109818034-G-C not specified Uncertain significance (Jan 19, 2025)3852839
4-109818051-T-G not specified Uncertain significance (Aug 21, 2023)2590247
4-109818079-C-T not specified Uncertain significance (Nov 25, 2024)3518737
4-109819014-A-C not specified Uncertain significance (Sep 29, 2023)3098324
4-109822405-G-A not specified Uncertain significance (Jun 24, 2022)2296176
4-109822426-G-C not specified Uncertain significance (Feb 12, 2024)3098325
4-109822482-A-G not specified Uncertain significance (Jun 07, 2024)3280704
4-109823989-G-C not specified Uncertain significance (Dec 11, 2024)3852840
4-109824424-G-A not specified Uncertain significance (Dec 15, 2023)3098326

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GAR1protein_codingprotein_codingENST00000226796 69228
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.1000.893125717051257220.0000199
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2321101170.9400.000005331349
Missense in Polyphen2929.9980.96673409
Synonymous0.4023639.20.9180.00000171460
Loss of Function2.37413.30.3007.28e-7153

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009150.0000913
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00002670.0000264
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Required for ribosome biogenesis and telomere maintenance. Part of the H/ACA small nucleolar ribonucleoprotein (H/ACA snoRNP) complex, which catalyzes pseudouridylation of rRNA. This involves the isomerization of uridine such that the ribose is subsequently attached to C5, instead of the normal N1. Each rRNA can contain up to 100 pseudouridine ("psi") residues, which may serve to stabilize the conformation of rRNAs. May also be required for correct processing or intranuclear trafficking of TERC, the RNA component of the telomerase reverse transcriptase (TERT) holoenzyme. {ECO:0000269|PubMed:10757788, ECO:0000269|PubMed:15044956}.;
Pathway
Ribosome biogenesis in eukaryotes - Homo sapiens (human);rRNA processing;Metabolism of RNA;rRNA modification in the nucleus and cytosol;rRNA processing in the nucleus and cytosol (Consensus)

Recessive Scores

pRec
0.125

Intolerance Scores

loftool
0.255
rvis_EVS
0.35
rvis_percentile_EVS
73.97

Haploinsufficiency Scores

pHI
0.159
hipred
Y
hipred_score
0.794
ghis
0.527

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
N
gene_indispensability_score
0.388

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Gar1
Phenotype
homeostasis/metabolism phenotype;

Gene ontology

Biological process
snoRNA guided rRNA pseudouridine synthesis;telomere maintenance via telomerase
Cellular component
nuclear chromosome, telomeric region;fibrillar center;nucleus;nucleoplasm;telomerase holoenzyme complex;box H/ACA snoRNP complex;box H/ACA scaRNP complex;box H/ACA telomerase RNP complex
Molecular function
RNA binding;protein binding;box H/ACA snoRNA binding;telomerase RNA binding